Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Trials|September 19, 2014
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?James M S Wason, Lynne Stecher, Adrian P ManderPlos One|July 13, 2016
AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical TrialsGraham M Wheeler, Michael J Sweeting, Adrian P ManderJournal of the Royal Statistical Society. Series C, Applied Statistics|March 19, 2019
A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity dataGraham M Wheeler, Michael J Sweeting, Adrian P ManderBiometrical Journal. Biometrische Zeitschrift|October 7, 2025
Multivariate Bayesian Dynamic Borrowing for Repeated Measures Data With Application to External Control Arms in Open-Label Extension StudiesBenjamin F Hartley, Matthew A Psioda, Adrian P ManderStatistics in Medicine|March 16, 2017
Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trialsGraham M Wheeler, Michael J Sweeting, Adrian P ManderEuropean Journal of Cancer (Oxford, England : 1990)|January 18, 2011
Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-pointsJames M S Wason, Adrian P Mander, Tim G EisenStatistics in Medicine|December 6, 2011
Optimal multistage designs for randomised clinical trials with continuous outcomesJames M S Wason, Adrian P Mander, Simon G ThompsonEuropean Journal of Cancer (Oxford, England : 1990)|March 28, 2022
When is a two-stage single-arm trial efficient? An evaluation of the impact of outcome delayAritra Mukherjee, James M S Wason, Michael J GraylingStatistics in Medicine|August 28, 2024
A hybrid approach to sample size re-estimation in cluster randomized trials with continuous outcomesSamuel K Sarkodie, James Ms Wason, Michael J GraylingWorld Neurosurgery|May 4, 2022
Adaptive Designs: Benefits and Cautions for Neurosurgery TrialsAritra Mukherjee, Michael J Grayling, James M S WasonPageof 10